Stryker SYK Net debt / EBITDA

Net debt / EBITDA at other companies

Baxter InternationalBAX

-2.7×+6.5×

Johnson & JohnsonJNJ

0.8×-0.3×

CONMEDCNMD

6.1×+2.3×

Merit Medical SystemsMMSI

1.1×-0.5×

Boston ScientificBSX

-0.1×-2.9×

VericelVCEL

-1×-3.1×

FAQ

What is Stryker's net debt / EBITDA?

Stryker (SYK) reported net debt / EBITDA of 1.9× in Q1 2026.

How has Stryker's net debt / EBITDA changed year-over-year?

Stryker's net debt / EBITDA decreased by 41.5% year-over-year, from 3.2× to 1.9×.

What is the long-term trend for Stryker's net debt / EBITDA?

Over 5 years (2020 to 2025), Stryker's net debt / EBITDA has grown at a -13.2% compound annual growth rate (CAGR), from 3.7× to 1.8×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.